Terms: = Thyroid cancer AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG
51 results:
1. Novel T cell exhaustion gene signature to predict prognosis and immunotherapy response in thyroid carcinoma from integrated RNA-sequencing analysis.
Li Y; Wang Z; Lu F; Miao Y; Feng Q; Zhu W; Kang Q; Chen Y; Zhang Q
Sci Rep; 2024 Apr; 14(1):8375. PubMed ID: 38600248
[TBL] [Abstract] [Full Text] [Related]
2. Adjuvant chemotherapy and survival in males aged 70 years or older with breast cancer: a population-based retrospective study.
Yu Y; Huang K; Liu Y; Chen R; Yu X; Song C
BMC Geriatr; 2024 Mar; 24(1):282. PubMed ID: 38528444
[TBL] [Abstract] [Full Text] [Related]
3. Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III non-small-cell lung cancer: Results from the phase 1 CLOVER study.
Kim DW; Chul Cho B; Pachipala K; Kim SW; Wang CL; Chang GC; Ahn MJ; Alvarez R; Chiu CH; Trigo J; Estival A; Karam SD; O'Brien C; Gowda H; Jiang H; Bauman JE
Lung Cancer; 2024 Apr; 190():107530. PubMed ID: 38471416
[TBL] [Abstract] [Full Text] [Related]
4. Prediction model based on MRI morphological features for distinguishing benign and malignant thyroid nodules.
Zheng T; Wang L; Wang H; Tang L; Xie X; Fu Q; Wu PY; Song B
BMC Cancer; 2024 Feb; 24(1):256. PubMed ID: 38395783
[TBL] [Abstract] [Full Text] [Related]
5. Single-cell RNA-seq reveals MIF-(cd74 + CXCR4) dependent inhibition of macrophages in metastatic papillary thyroid carcinoma.
Chen W; Yu X; Li H; Yuan S; Fu Y; Hu H; Liu F; Zhang Y; Zhong S
Oral Oncol; 2024 Jan; 148():106654. PubMed ID: 38061122
[TBL] [Abstract] [Full Text] [Related]
6. Patient-reported outcomes with durvalumab, with or without tremelimumab, plus chemotherapy as first-line treatment for metastatic non-small-cell lung cancer (POSEIDON).
Garon EB; Cho BC; Luft A; Alatorre-Alexander J; Geater SL; Kim SW; Ursol G; Hussein M; Lim FL; Yang CT; Araujo LH; Saito H; Reinmuth N; Medic N; Mann H; Shi X; Peters S; Mok T; Johnson M
Lung Cancer; 2023 Dec; 186():107422. PubMed ID: 37992595
[TBL] [Abstract] [Full Text] [Related]
7. Prevalence and impact of non-alcoholic fatty liver disease in patients with papillary thyroid carcinoma.
Xiao R; Ni C; Cai Y; Zhou Y; Gong X; Xie K; You J
Endocrine; 2023 Jun; 80(3):619-629. PubMed ID: 36696026
[TBL] [Abstract] [Full Text] [Related]
8. Association of thyroid-Stimulating Hormone With All-Cause Mortality: A 2-Sample Mendelian Randomization Study.
Gu Y; Song Z; Li Q; Wang J; Song Y; Meng G; Wu H; Zhang S; Wang X; Zhang J; Lu X; Liu Q; Huang T; Yang J; Niu K
J Clin Endocrinol Metab; 2023 Jun; 108(7):e396-e403. PubMed ID: 36658102
[TBL] [Abstract] [Full Text] [Related]
9. Development of a machine learning-based fine-grained risk stratification system for thyroid nodules using predefined clinicoradiological features.
Ha EJ; Lee JH; Lee DH; Na DG; Kim JH
Eur Radiol; 2023 May; 33(5):3211-3221. PubMed ID: 36600122
[TBL] [Abstract] [Full Text] [Related]
10. Metformin and thyroid carcinoma incidence and prognosis: A systematic review and meta-analysis.
Wang Z; Luo J; Zhang Y; Xun P; Chen Z
PLoS One; 2022; 17(7):e0271038. PubMed ID: 35901016
[TBL] [Abstract] [Full Text] [Related]
11. Deep convolutional neural networks in thyroid disease detection: A multi-classification comparison by ultrasonography and computed tomography.
Zhang X; Lee VC; Rong J; Lee JC; Liu F
Comput Methods Programs Biomed; 2022 Jun; 220():106823. PubMed ID: 35489145
[TBL] [Abstract] [Full Text] [Related]
12. Temporal Trends in Papillary and Follicular thyroid cancer Incidence from 1995 to 2019 in Adults in Denmark According to Education and Income.
Sørensen SM; de la Cour CD; Maltesen T; Urbute A; Kjaer SK
Thyroid; 2022 Aug; 32(8):972-982. PubMed ID: 35459415
[No Abstract] [Full Text] [Related]
13. Evaluation of the AFIAS-1 thyroid-stimulating hormone point of care test and comparison with laboratory-based devices.
Dierks S; Andag R; Gauss F; Budde K; Francke P; Peschka M; Fischer A; Schanz J; Petersmann A
Clin Chem Lab Med; 2022 Jun; 60(7):1031-1038. PubMed ID: 35451300
[TBL] [Abstract] [Full Text] [Related]
14. Preoperative comprehensive malignancy risk estimation for thyroid nodules: Development and verification of a network-based prediction model.
Shao G; Sun B; Shi M; Song Y; Sun Z; Hao X; Li L; Fu Z
Eur J Surg Oncol; 2022 Jun; 48(6):1264-1271. PubMed ID: 35367109
[TBL] [Abstract] [Full Text] [Related]
15. Analysis of correlation factors influencing the outcome of initial 131I remnant ablative therapy in intermediate- to high-risk patients with papillary thyroid microcarcinoma.
Wu R; Liu W; Li N; Wang X; Sun D; Ji Y; Jia Q; Tan J; Zheng W
Nucl Med Commun; 2022 Jun; 43(6):669-674. PubMed ID: 35351838
[TBL] [Abstract] [Full Text] [Related]
16. Could Urinary Iodine Be an Effective Predictive Factor for thyroid cancer After High Dose Radioactive Iodine Therapy?
Cao J; Yun C; Zhu X; Sun Y; Li X; Zhang W
Endocr Pract; 2022 Jun; 28(6):586-592. PubMed ID: 35304327
[TBL] [Abstract] [Full Text] [Related]
17. The Relationship and Gender Disparity Between thyroid Nodules and Metabolic Syndrome Components Based on a Recent Nationwide Cross-Sectional Study and Meta-Analysis.
Zhang F; Li Y; Yu X; Wang X; Lin Z; Song B; Tian L; Feng C; Shan Z; Teng W
Front Endocrinol (Lausanne); 2021; 12():736972. PubMed ID: 34621243
[TBL] [Abstract] [Full Text] [Related]
18. A meta-analysis of the influence of body mass index on the clinicopathologic progression of papillary thyroid carcinoma.
Cui N; Sun Q; Chen L
Medicine (Baltimore); 2021 Aug; 100(32):e26882. PubMed ID: 34397906
[TBL] [Abstract] [Full Text] [Related]
19. Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors and Sudden Cardiac Arrest and Ventricular Arrhythmia: Population-Based Cohort Studies.
Dawwas GK; Hennessy S; Brensinger CM; Deo R; Bilker WB; Soprano SE; Dhopeshwarkar N; Flory JH; Bloomgarden ZT; Aquilante CL; Kimmel SE; Leonard CE
Clin Pharmacol Ther; 2022 Jan; 111(1):227-242. PubMed ID: 34331322
[TBL] [Abstract] [Full Text] [Related]
20. Construction and validation of a nomogram for predicting cervical lymph node metastasis in classic papillary thyroid carcinoma.
Feng Y; Min Y; Chen H; Xiang K; Wang X; Yin G
J Endocrinol Invest; 2021 Oct; 44(10):2203-2211. PubMed ID: 33586026
[TBL] [Abstract] [Full Text] [Related]
[Next]
